An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

NCT07029555 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
57
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals